ProfileGDS5822 / ILMN_2611180
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 71% 77% 69% 71% 69% 67% 64% 80% 65% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 155.871
GSM1276600PDAC Late Ablation Control 2107.577
GSM1276601PDAC Late Ablation Control 367.369
GSM1276602PDAC Late Ablation 154.571
GSM1276603PDAC Late Ablation 252.769
GSM1276604PDAC Late Ablation 34867
GSM1303940PDAC Late Ablation_anti-CTLA4 133.464
GSM1303941PDAC Late Ablation_anti-CTLA4 2183.880
GSM1303942PDAC Late Ablation_anti-CTLA4 348.865